|
Oct 1
|
ENHERTU® (fam-trastuzumab deruxtecan-nxki) granted Priority Review in the US for patients with HER2-low or HER2-ultralow metastatic breast cancer who have received at least one line of endocrine therapy
|
|
Sep 30
|
AstraZeneca (AZN): A Strong Buy as FDA Approves Key Cancer Treatments and Revenue Surges
|
|
Sep 30
|
Is AstraZeneca PLC (NASDAQ:AZN) The Top Global Stock To Buy Now?
|
|
Sep 29
|
Is AstraZeneca PLC (AZN) the Best Cheap Growth Stock to Buy According to Analysts?
|
|
Sep 28
|
15 Unhealthiest Countries in Europe
|
|
Sep 27
|
Pharma Stock Roundup: JNJ's 3rd Talc-Related Bankruptcy Filing & More
|
|
Sep 27
|
The Zacks Analyst Blog Highlights Toyota Motor, AstraZeneca, Chubb, Air T and Preformed Line Products
|
|
Sep 27
|
US’ first self-administered flu vaccine could increase accessibility and uptake
|
|
Sep 27
|
ANGLE PLC (ANPCY) (Q2 2024) Earnings Call Transcript Highlights: Key Takeaways from the ...
|
|
Sep 27
|
AstraZeneca’s Tagrisso gains FDA approval for stage III NSCLC
|
|
Sep 26
|
Top Stock Reports for Toyota, AstraZeneca & Chubb
|
|
Sep 26
|
AstraZeneca Stock Up Almost 14% in 6 Months: Time to Buy?
|
|
Sep 26
|
AZN's Tagrisso Gets FDA Nod for Expanded Use in NSCLC
|
|
Sep 26
|
AstraZeneca's Top-Selling Cancer Drug Tagrisso Receives FDA Green Light For Another Lung Cancer Indication
|
|
Sep 26
|
Buy These 5 Big Drug Stocks to Boost Your Portfolio's Health
|
|
Sep 26
|
AstraZeneca in AI collaboration with Immunai to inform cancer drug trials
|
|
Sep 26
|
Deutsche Bank ADR Virtual Investor Conference: Presentations Now Available for Online Viewing
|
|
Sep 26
|
TAGRISSO® (osimertinib) approved in the US for patients with unresectable, Stage III EGFR-mutated lung cancer
|
|
Sep 25
|
Has Arbutus Biopharma (ABUS) Outpaced Other Medical Stocks This Year?
|
|
Sep 25
|
AstraZeneca PLC (AZN): A Risky Bet on Emerging Cancer Treatments
|